DrugRepV_6178 | Ribavirin | Antiinfectives For Systemic Use | Hepatitis C virus | Dengue virus | ThNH-7/93 | | Fluorescent focus-forming assay | Decrease (50 %) | Approved | 22784856 |
DrugRepV_6179 | (1S,2R,3S,4S)-3,4-dihydroxy-2-(hydroxymethyl)-1-[(2S,3S,4R,5R,6S)-2,4,5,6,7-pentahydroxy-3-(sulfonatooxy)heptyl]thiolan-1-ium | NA | NA | Dengue virus | ThNH-7/93 | | Fluorescent focus-forming assay | Decrease (50 %) | NA | 22784856 |
DrugRepV_6180 | (1R,2R,3S,4S)-1-[(2S,3S,4R,5R,6S)-2,3,4,5,6,7-hexahydroxyheptyl]-3,4-dihydroxy-2-(hydroxymethyl)thiolan-1-ium chloride | NA | NA | Dengue virus | ThNH-7/93 | | Fluorescent focus-forming assay | Decrease (50 %) | NA | 22784856 |